Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
On Friday, Charles Schwab Corp. ( SCHW - Analyst Report ) released its Monthly Activity Report for April 2011, recording net outflows of $0.5 billion in net new assets (including both new and existing clients) as the customers withdrew money to pay income taxes. This is the first time that the company has reported a net outflow since June 2010.
However, Schwab’s client assets totaled $1.68 trillion at the end of April, reflecting a growth of 2% from the prior month and 11% on a year-over-year basis. The hike was driven by an increase in net market gains (due to rising markets), which was partially offset by a decline in net new assets.
Schwab reported opening of 83,000 brokerage accounts in April 2011. This was higher than 82,000 registered in March but lower than 89,000 recorded in April 2010. Schwab also reported a slow down in trading activity in April. The company’s daily average trades were 435,000 in April, flat with the prior month but down 1% year over year.
At the end of April, Schwab’s clients’ active brokerage accounts totaled 8.112 million, flat with the prior month but up 3% year over year. Similarly, clients’ banking accounts stood at 728,000, showing an increase of 1% sequentially and 18% year over year. However, the number of corporate retirement plan participants declined 1% from March 2011 and 2% from April 2010 to 1,436 million.
While Schwab’s focus on lower-cost capital structure will sustain better results in the upcoming quarters, its financials will continue to be affected by lower trading activities and volatile interest rates. However, after the completion of the acquisition of optionsXpress Holdings Inc. ( ) in the third quarter of 2011, the company’s top line will benefit from increased trading in derivatives. Also, capital spending initiatives will augment further revenue growth.
Schwab currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. Also, considering the fundamentals, we maintain a long-term Neutral recommendation on the stock.
Read the full Analyst Report on SCHW